<DOC>
	<DOCNO>NCT01793103</DOCNO>
	<brief_summary>The goal present study establish prospective observational cohort Rheumatoid Arthritis patient order 1 . Determine validate biomarkers predict drug response toxicity RA . 2 . Determine validate biomarkers predict disease activity prognosis RA . 3 . Evaluate natural history treat RA term clinical , functional economic outcome .</brief_summary>
	<brief_title>Brigham Women 's Rheumatoid Arthritis Sequential Study</brief_title>
	<detailed_description>The Registry prospective observational study total 1600 patient diagnose RA . Patients 18 year age great , patient R.B . Brigham Arthritis Center diagnose RA meet entry criterion . Once patient agree participate sign inform consent form , undergo detailed baseline examination include demographic clinical information , functional status , disease activity , comorbidity , laboratory test hand radiograph . RA criterion determine rheumatologist document ACR criterion medical record review . The primary outcome interest presence erosive extra-articular disease , decline functional status significant drug toxicity . A sample blood urine store DNA/RNA test . During time either interview self-administered questionnaire , ask information disease severity , functional status , resource utilization , level fatigue , employment status , medication adverse event . Information obtain time enrollment Registry , annual examination , semi-annual questionnaire annual follow-up visit , well medical record . Subjects follow 5 year time ask would like consent additional 5 year . At 10 year visit , subject still enrol give option consent additional 5 year . Subjects give option within consent form agree collection discard specimen analyze cell soluble factor proteins blood determine affect course rheumatoid arthritis develop different individual . Patients bill diagnosis RA ( 714.0 ) seronegative inflammatory arthritis ( 714.9 ) age 18 year old enrol Robert Breck Brigham Arthritis Center eligible recruitment . Rheumatologists within Division Rheumatology , Immunology Allergy evaluate patient R.B . Brigham Arthritis Center ask permission contact patient tentative diagnosis RA base upon ICD billing code . A letter describe study , Dr. Nancy Shadick , primary rheumatologist send subject 7-10 day prior next scheduled visit . The consent form include letter time discuss family others . In case non-English speaking patient , short form consent form present interpreter supply . A letter describe study , sign Dr. Shadick , PI , patient 's primary rheumatologist send patient 7-10 day prior next scheduled visit . An informed consent document send time patient read discuss family others . If interested participating study , subject ask bring informed consent document appointment rheumatologist . Either participate rheumatologist research coordinator train explain protocol detail obtain consent . Each research coordinator involve obtain consent undergo 1 hour training session principal investigator , Nancy A. Shadick , MD . The investigator review general principle , benefit risk genetic analysis well detail study . All subject must able give consent study .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>1 . Are 18 year age old ; 2 . Are patient register R.B.Brigham Arthritis Center . 3 . Have , time enrollment diagnosis RA make board certified rheumatologist . 4 . Are able willing provide inform consent . le 18 year age diagnosis RA history SLE Psoriasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>